MetaADEDB 2.0 @ LMMD
Rabeprazole
(YREYEVIYCVEVJK-UHFFFAOYSA-N)
Structure
SMILES
COCCCOc1ccnc(c1C)CS(=O)c1nc2c([nH]1)cccc2
Type(s)
Approved; Investigational
ATC code(s)
A02BC04; A02BC54; M01AA05; M02AA03
Molecular Formula:
C18H21N3O3S
Molecular Weight:
359.443
Log P:
3.8551
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
1
TPSA:
96.31
CAS Number(s):
117976-89-3
Synonym(s)
1.
Rabeprazole
2.
1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, Sodium Salt
3.
2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzimidazole
4.
Aciphex
5.
Dexrabeprazole
6.
E 3810
7.
E3810
8.
LY-307640
9.
LY307640
10.
Pariet
11.
Rabeprazole Sodium
12.
LY 307640
13.
Sodium, Rabeprazole
External Link(s)
MeSHD064750
PubChem Compound5029
BindingDB50070209
ChEBI8768
CHEMBLCHEMBL1219
DrugBankDB01129
DrugCentral2350
IUPHAR/BPS Guide to PHARMACOLOGY7290
KEGGcpd:C07864
dr:D08463
Therapeutic Target DatabaseD0KL4J
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 64
Canada Vigilance: 106
Canada Vigilance
US FAERS
2HeadacheFAERS: 21
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
3DyspepsiaFAERS: 20
Canada Vigilance: 16
15705174
17609230
CTD
SIDER
Canada Vigilance
US FAERS
4Product substitution issueFAERS: 20
Canada Vigilance: 39
Canada Vigilance
US FAERS
5NauseaFAERS: 18
Canada Vigilance: 21
Canada Vigilance
OFFSIDES
SIDER
US FAERS
6Abdominal PainFAERS: 14
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
7Chest PainFAERS: 14
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
8DizzinessFAERS: 13
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
9Myocardial InfarctionFAERS: 12SIDER
US FAERS
10PalpitationsFAERS: 12SIDER
US FAERS
11ArthralgiaFAERS: 10SIDER
US FAERS
12Weight decreasedFAERS: 10SIDER
US FAERS
13Cerebrovascular accidentFAERS: 9US FAERS
14UrticariaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
15FlatulenceFAERS: 8
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
16PruritusFAERS: 8
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
17ConstipationFAERS: 7SIDER
US FAERS
18FatigueFAERS: 7
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
US FAERS
19HypersensitivityFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
20MalaiseFAERS: 7
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
21PainFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
22VomitingFAERS: 7
Canada Vigilance: 12
Canada Vigilance
SIDER
US FAERS
23Abdominal discomfortFAERS: 6
Canada Vigilance: 15
Canada Vigilance
US FAERS
24Feeling abnormalFAERS: 6SIDER
US FAERS
25MyalgiaFAERS: 6SIDER
US FAERS
26OsteoporosisFAERS: 6US FAERS
27PneumoniaFAERS: 6SIDER
US FAERS
28Product quality issueFAERS: 6US FAERS
29Respiratory FailureFAERS: 6SIDER
US FAERS
30Back PainFAERS: 5SIDER
US FAERS
31DiscomfortFAERS: 5SIDER
US FAERS
32Memory impairmentFAERS: 5US FAERS
33AgeusiaFAERS: 4US FAERS
34AnxietyFAERS: 4SIDER
US FAERS
35Oropharyngeal painFAERS: 4US FAERS
36Pharmaceutical product complaintFAERS: 4US FAERS
37Throat irritationFAERS: 4US FAERS
38TremorFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
39Acute kidney injuryFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
40Adverse eventFAERS: 3US FAERS
41AsthmaFAERS: 3SIDER
US FAERS
42ColitisFAERS: 3SIDER
US FAERS
43DeafnessFAERS: 3SIDER
US FAERS
44Disease recurrenceFAERS: 3US FAERS
45DiverticulitisFAERS: 3US FAERS
46Drug dose omissionFAERS: 3US FAERS
47EructationFAERS: 3
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
48GastritisFAERS: 316249975
17523409
CTD
SIDER
US FAERS
49Gastrointestinal PainFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
50Middle insomniaFAERS: 3US FAERS
51Musculoskeletal stiffnessFAERS: 3OFFSIDES
SIDER
US FAERS
52WheezingFAERS: 3US FAERS
53Alanine Aminotransferase IncreasedFAERS: 2SIDER
US FAERS
54AlopeciaFAERS: 2SIDER
US FAERS
55AngioedemaFAERS: 2SIDER
US FAERS
56Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
57AstheniaFAERS: 2
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
58Atrial FibrillationFAERS: 2US FAERS
59Autonomic neuropathyFAERS: 2US FAERS
60BlindnessFAERS: 2US FAERS
61Bone painFAERS: 2SIDER
US FAERS
62BronchiectasisFAERS: 2OFFSIDES
US FAERS
63Burning sensationFAERS: 2US FAERS
64CarcinomaFAERS: 2SIDER
US FAERS
65Carpal Tunnel SyndromeFAERS: 2US FAERS
66Chest discomfortFAERS: 2US FAERS
67ChillsFAERS: 2SIDER
US FAERS
68CystitisFAERS: 2SIDER
US FAERS
69DysgeusiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
70FolliculitisFAERS: 2US FAERS
71HypoxiaFAERS: 2OFFSIDES
SIDER
US FAERS
72Impaired gastric emptyingFAERS: 2US FAERS
73Intentional dose omissionFAERS: 2US FAERS
74Irritable Bowel SyndromeFAERS: 2US FAERS
75Magnesium DeficiencyFAERS: 2US FAERS
76Musculoskeletal PainFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
77Nerve injuryFAERS: 2US FAERS
78NervousnessFAERS: 2SIDER
US FAERS
79Nutritional condition abnormalFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
80Pancreatic carcinomaFAERS: 2US FAERS
81Product storage errorFAERS: 2US FAERS
82Pulmonary EmbolismFAERS: 2SIDER
US FAERS
83Pulmonary congestionFAERS: 2US FAERS
84RhabdomyolysisFAERS: 2OFFSIDES
SIDER
US FAERS
85SepsisFAERS: 2US FAERS
86SyncopeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
87Tardive DyskinesiaFAERS: 2US FAERS
88TenosynovitisFAERS: 2OFFSIDES
US FAERS
89Throat cancerFAERS: 2US FAERS
90TinnitusFAERS: 2SIDER
US FAERS
91Visual ImpairmentFAERS: 2SIDER
US FAERS
92Abnormal sleep-related eventFAERS: 1US FAERS
93AcneFAERS: 1OFFSIDES
US FAERS
94Acute myocardial infarctionFAERS: 1US FAERS
95AmnesiaFAERS: 1SIDER
US FAERS
96Amniotic fluid volume decreasedFAERS: 1US FAERS
97Angina PectorisFAERS: 1SIDER
US FAERS
98AnosmiaFAERS: 1US FAERS
99Antinuclear antibody negativeFAERS: 1US FAERS
100ApathyFAERS: 1US FAERS
101Apparent deathFAERS: 1US FAERS
102AtaxiaFAERS: 1OFFSIDES
US FAERS
103Bladder painFAERS: 1SIDER
US FAERS
104Blood alkaline phosphatase increasedFAERS: 1US FAERS
105Blood creatine phosphokinase increasedFAERS: 1SIDER
US FAERS
106Blood gastrin increasedFAERS: 1OFFSIDES
US FAERS
107Blood glucose increasedFAERS: 1US FAERS
108Blood magnesium decreasedFAERS: 1US FAERS
109Bone density decreasedFAERS: 1US FAERS
110BronchospasmFAERS: 1US FAERS
111CachexiaFAERS: 1US FAERS
112Cardiac ArrestFAERS: 1US FAERS
113Choking sensationFAERS: 1US FAERS
114ChokingFAERS: 1US FAERS
115CholelithiasisFAERS: 1SIDER
US FAERS
116ChromaturiaFAERS: 1OFFSIDES
US FAERS
117Clostridium difficile colitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
118Cold sweatFAERS: 1US FAERS
119Completed SuicideFAERS: 1US FAERS
120Coronary Artery DiseaseFAERS: 1SIDER
US FAERS
121Creatinine renal clearance decreasedFAERS: 1US FAERS
122DehydrationFAERS: 1SIDER
US FAERS
123Diabetes MellitusFAERS: 1SIDER
US FAERS
124Diabetic RetinopathyFAERS: 1US FAERS
125Diastolic hypertensionFAERS: 1US FAERS
126DiplopiaFAERS: 1SIDER
US FAERS
127Documented hypersensitivity to administered drugFAERS: 1US FAERS
128Drug ToleranceFAERS: 1US FAERS
129Drug exposure during pregnancyFAERS: 1US FAERS
130Drug prescribing errorFAERS: 1US FAERS
131DysenteryFAERS: 1US FAERS
132DysphoniaFAERS: 1US FAERS
133Ear discomfortFAERS: 1US FAERS
134False negative laboratory resultFAERS: 1US FAERS
135Feeling ColdFAERS: 1US FAERS
136Feeling jitteryFAERS: 1US FAERS
137Full blood count decreasedFAERS: 1US FAERS
138Gastric DilatationFAERS: 1US FAERS
139Gastric pH decreasedFAERS: 1US FAERS
140General physical health deteriorationFAERS: 1US FAERS
141GingivitisFAERS: 1SIDER
US FAERS
142GlossitisFAERS: 1SIDER
US FAERS
143Head titubationFAERS: 1US FAERS
144HemiparesisFAERS: 1US FAERS
145Hepatitis B surface antigen positiveFAERS: 1US FAERS
146HepatitisFAERS: 1SIDER
US FAERS
147Hypoaesthesia facialFAERS: 1US FAERS
148HypothyroidismFAERS: 1SIDER
US FAERS
149Impaired work abilityFAERS: 1US FAERS
150Inappropriate schedule of drug administrationFAERS: 1US FAERS
151IncontinenceFAERS: 1US FAERS
152Incorrect dose administeredFAERS: 1US FAERS
153Incorrect drug administration durationFAERS: 1US FAERS
154InflammationFAERS: 1US FAERS
155Initial insomniaFAERS: 1US FAERS
156Intentional product misuseFAERS: 1US FAERS
157Intestinal PerforationFAERS: 1OFFSIDES
US FAERS
158Joint stiffnessFAERS: 1US FAERS
159Joint swellingFAERS: 1US FAERS
160LaryngospasmFAERS: 1US FAERS
161Lip swellingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
162Loss of dreamingFAERS: 1US FAERS
163LymphadenopathyFAERS: 1SIDER
US FAERS
164LymphomaFAERS: 1US FAERS
165Malignant neoplasm progressionFAERS: 1OFFSIDES
US FAERS
166MalnutritionFAERS: 1SIDER
US FAERS
167Maternal exposure during pregnancyFAERS: 1US FAERS
168Mechanical urticariaFAERS: 1US FAERS
169Medication ErrorFAERS: 1US FAERS
170Meniscus injuryFAERS: 1US FAERS
171MenopauseFAERS: 1US FAERS
172NephrolithiasisFAERS: 1SIDER
US FAERS
173No adverse effectFAERS: 1US FAERS
174No adverse eventFAERS: 1US FAERS
175No reaction on previous exposure to drugFAERS: 1US FAERS
176Ocular icterusFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
177Optic nerve infarctionFAERS: 1US FAERS
178Oral painFAERS: 1US FAERS
179Peripheral swellingFAERS: 1US FAERS
180Perirectal abscessFAERS: 1OFFSIDES
US FAERS
181Pharyngolaryngeal PainFAERS: 1US FAERS
182PhotophobiaFAERS: 1US FAERS
183Poor quality drug administeredFAERS: 1US FAERS
184Post procedural complicationFAERS: 1US FAERS
185PregnancyFAERS: 1US FAERS
186Product coating issueFAERS: 1US FAERS
187Productive CoughFAERS: 1US FAERS
188Pulmonary sepsisFAERS: 1US FAERS
189Pulmonary thrombosisFAERS: 1US FAERS
190Rash follicularFAERS: 1US FAERS
191Reaction to drug excipientsFAERS: 1US FAERS
192Refusal of treatment by relativeFAERS: 1US FAERS
193Renal painFAERS: 1US FAERS
194Respiratory arrestFAERS: 1US FAERS
195Respiratory distressFAERS: 1US FAERS
196Respiratory tract congestionFAERS: 1US FAERS
197RetchingFAERS: 1US FAERS
198RhinitisFAERS: 1SIDER
US FAERS
199Salivary gland painFAERS: 1US FAERS
200SinusitisFAERS: 1SIDER
US FAERS
201Small intestine carcinomaFAERS: 1OFFSIDES
US FAERS
202SomnolenceFAERS: 1SIDER
US FAERS
203Stevens-Johnson SyndromeFAERS: 125811541CTD
SIDER
US FAERS
204StomatitisFAERS: 1SIDER
US FAERS
205Supraventricular tachycardiaFAERS: 1SIDER
US FAERS
206Suspected counterfeit productFAERS: 1US FAERS
207SwellingFAERS: 1US FAERS
208TachycardiaFAERS: 1SIDER
US FAERS
209Therapeutic product effect decreasedFAERS: 1US FAERS
210Therapeutic response changedFAERS: 1
Canada Vigilance: 17
Canada Vigilance
US FAERS
211Therapy non-responderFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
212Thermal burnFAERS: 1US FAERS
213ThirstFAERS: 1SIDER
US FAERS
214ThrombocytopeniaFAERS: 1SIDER
US FAERS
215ThrombosisFAERS: 1SIDER
US FAERS
216Tongue bitingFAERS: 1OFFSIDES
US FAERS
217Tongue blisteringFAERS: 1US FAERS
218ToothacheFAERS: 1US FAERS
219Unevaluable eventFAERS: 1US FAERS
220Urine bilirubin increasedFAERS: 1US FAERS
221Vitamin D DeficiencyFAERS: 1US FAERS
222Vitreous floatersFAERS: 1US FAERS
223jaundiceFAERS: 1SIDER
US FAERS
224AbasiaOFFSIDES
225Abnormal plateletsSIDER
226Abnormal visionSIDER
227AbscessSIDER
228Accidental exposureOFFSIDES
229Acid refluxOFFSIDES
230Activities of daily living impairedOFFSIDES
231Acute Coronary SyndromeSIDER
232AgitationSIDER
233AgranulocytosisSIDER
234AlbuminuriaSIDER
235Altered state of consciousnessOFFSIDES
236AmblyopiaSIDER
237AmenorrheaOFFSIDES
238Anal abscessOFFSIDES
239Anaphylactic shockSIDER
240AnorexiaOFFSIDES
SIDER
241Anticoagulation drug level above therapeuticOFFSIDES
242AnuriaOFFSIDES
243Aortic valve sclerosisOFFSIDES
244AphasiaCanada Vigilance: 1Canada Vigilance
245Arteriosclerosis ObliteransOFFSIDES
246ArthritisSIDER
247ArthropathyOFFSIDES
SIDER
248AscitesOFFSIDES
SIDER
249Aspiration PneumoniaOFFSIDES
250AtelectasisOFFSIDES
251Atrioventricular BlockOFFSIDES
252Autoimmune hepatitisOFFSIDES
253Bacterial EndocarditisOFFSIDES
254Basophil percentage increasedOFFSIDES
255Benign Prostatic HyperplasiaOFFSIDES
256Benign neoplasm of skinSIDER
257BicytopeniaSIDER
258Biliary DyskinesiaOFFSIDES
259BlepharitisSIDER
260Blood GlucoseOFFSIDES
261Blood albumin decreasedOFFSIDES
262Blood beta-D-glucan increasedOFFSIDES
263Blood bilirubin abnormalOFFSIDES
264Blood cholesterolOFFSIDES
265Blood creatinine increasedOFFSIDES
266Blood iron abnormalOFFSIDES
267Blood iron increasedOFFSIDES
268Blood osmolarity decreasedOFFSIDES
269Blood pH increasedOFFSIDES
270Blood potassium increasedOFFSIDES
271Blood prolactin increasedCanada Vigilance: 1Canada Vigilance
272Blood uric acidOFFSIDES
273BotulismOFFSIDES
274BradycardiaSIDER
275Brain ConcussionOFFSIDES
276Breast tendernessCanada Vigilance: 1Canada Vigilance
OFFSIDES
277BronchitisSIDER
278BronchopneumoniaOFFSIDES
279Budd-Chiari SyndromeOFFSIDES
280BunionOFFSIDES
281BursitisOFFSIDES
SIDER
282CD4 Lymphocytes DecreasedOFFSIDES
283Carcinoma of lungSIDER
284Cardiac stress test abnormalOFFSIDES
285CataractSIDER
286Catheter related complicationOFFSIDES
287Cauda Equina SyndromeOFFSIDES
288CellulitisSIDER
289Cerebellar AtaxiaOFFSIDES
290CholangitisSIDER
291CholecystitisOFFSIDES
SIDER
292Citrobacter infectionOFFSIDES
293Compression fractureOFFSIDES
294Confusion17609230CTD
295Congenital cystic kidney diseaseSIDER
296ConjunctivitisSIDER
297Corneal OpacitySIDER
298Corneal PerforationOFFSIDES
299Cramps of lower extremitiesSIDER
300Creatine Phosphokinase IncreasedSIDER
301Cytomegalovirus chorioretinitisOFFSIDES
302DeliriumSIDER
303DementiaSIDER
304Dental cariesSIDER
305DermatitisSIDER
306Device dislocationOFFSIDES
307Diabetes mellitus inadequate controlOFFSIDES
308DiarrheaOFFSIDES
309Diffuse Large B-Cell LymphomaOFFSIDES
310DisorientationSIDER
311Disseminated Intravascular CoagulationOFFSIDES
312Dissociative disorderOFFSIDES
313Disturbance in sexual arousalSIDER
314DiverticulosisOFFSIDES
315Drug administration errorOFFSIDES
316Drug withdrawal headacheOFFSIDES
317Dry skinSIDER
318DuodenitisSIDER
319Dural tearOFFSIDES
320DysarthriaCanada Vigilance: 1Canada Vigilance
321DyscheziaOFFSIDES
322DysuriaOFFSIDES
SIDER
323EcchymosisSIDER
324EczemaOFFSIDES
325Electrocardiogram ST segment abnormalOFFSIDES
326Electrocardiogram abnormalSIDER
327EmbolismSIDER
328EmbolusSIDER
329EncephalitisOFFSIDES
330Endoscopy upper gastrointestinal tract abnormalCanada Vigilance: 1Canada Vigilance
331Enlargement abdomenSIDER
332Enterococcal sepsisOFFSIDES
333EpistaxisSIDER
334Erectile dysfunctionSIDER
335Erythema MultiformeSIDER
336ErythemaSIDER
337Esophageal Diseases22122999CTD
338Esophagitis11519776CTD
339Eye inflammationOFFSIDES
340Eye irritationCanada Vigilance: 1Canada Vigilance
341Eye painSIDER
342Facial NeuralgiaOFFSIDES
343Fibroadenoma of breastOFFSIDES
344Flank PainOFFSIDES
345FlushingCanada Vigilance: 2Canada Vigilance
346Focal glomerulosclerosisOFFSIDES
347FractureSIDER
348Gait inabilityCanada Vigilance: 1Canada Vigilance
349GastroenteritisSIDER
350Gastrointestinal Diseases12848632CTD
351Gastrointestinal carcinomaSIDER
352Gastrointestinal inflammationOFFSIDES
353Gastrointestinal mucosal disorderOFFSIDES
354Gene MutationOFFSIDES
355GlaucomaSIDER
356GoutOFFSIDES
SIDER
357GranulocytosisOFFSIDES
358Heartburn12848632CTD
359Helicobacter Infections21073372CTD
360HemiplegiaOFFSIDES
361Hepatic EncephalopathySIDER
362Hepatic congestionOFFSIDES
363Hepatic vein occlusionOFFSIDES
364HerniaSIDER
365Herpes NOSSIDER
366HyperkinesiaSIDER
367HyperreflexiaOFFSIDES
368HyperthyroidismSIDER
369HypertrichosisOFFSIDES
370HyperventilationSIDER
371HypotensionSIDER
372HypoventilationSIDER
373Ileal ulcerSIDER
374Immediate post-injection reactionOFFSIDES
375Incision site complicationOFFSIDES
376Infective spondylitisOFFSIDES
377Injection Site ReactionSIDER
378Injection site painSIDER
379IntubationOFFSIDES
380Kidney FailureOFFSIDES
381Lacrimal structural disorderSIDER
382Lactose IntoleranceCanada Vigilance: 1Canada Vigilance
383LaryngitisSIDER
384Leriche SyndromeOFFSIDES
385LeukocytosisSIDER
386Leukopenia neonatalOFFSIDES
387LeukopeniaSIDER
388LeukorrheaSIDER
389Liver fatty depositionSIDER
390Lung consolidationOFFSIDES
391Lung infection pseudomonalOFFSIDES
392Lymphangiosis carcinomatosaOFFSIDES
393Lymphocyte count decreasedOFFSIDES
394Lymphocyte stimulation test positiveOFFSIDES
395Lymphocytic infiltrationOFFSIDES
396MastitisSIDER
397MenorrhagiaSIDER
398Mental impairmentOFFSIDES
399Mental status changesOFFSIDES
400Metabolic acidosisCanada Vigilance: 1Canada Vigilance
401MetrorrhagiaSIDER
402Movement Disorders19519270CTD
403Muscle Weakness16758264CTD
404Musculoskeletal discomfortSIDER
405MydriasisCanada Vigilance: 1Canada Vigilance
406MyelitisOFFSIDES
407Neck PainSIDER
408Neck stiffnessSIDER
409Nephritis, Interstitial15705174
16630752
19682153
CTD
410Nephrotic SyndromeOFFSIDES
411NeuralgiaSIDER
412Neurogenic BowelOFFSIDES
413NeuropathySIDER
414NeutropeniaSIDER
415Night Terrors17609230CTD
416Non-cardiac chest painOFFSIDES
417Nuchal RigiditySIDER
418OliguriaOFFSIDES
419Orchitis noninfectiveSIDER
420OrchitisSIDER
421OrthopneaOFFSIDES
422Otitis ExternaSIDER
423Otitis MediaSIDER
424Pancreatic CystOFFSIDES
425Pancreatitis12619583CTD
OFFSIDES
SIDER
426PancytopeniaSIDER
427Panic Disorder17609230CTD
428PanniculitisOFFSIDES
429ParaplegiaOFFSIDES
430Pelvic PainSIDER
431Peritoneal perforationOFFSIDES
432PeritonitisOFFSIDES
433Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
434PharyngitisSIDER
435Platelet TransfusionOFFSIDES
436Platelet count abnormalOFFSIDES
437Pneumocystis jiroveci pneumoniaOFFSIDES
438PneumoperitoneumOFFSIDES
439PolyuriaSIDER
440Poor peripheral circulationOFFSIDES
441PoriomaniaOFFSIDES
442Post procedural infectionOFFSIDES
443ProctitisSIDER
444ProctocolitisSIDER
445Product solubility abnormalCanada Vigilance: 1Canada Vigilance
446Prostate cancer recurrentOFFSIDES
447Protein total decreasedOFFSIDES
448Prothrombin time ratio increasedOFFSIDES
449Psoas AbscessOFFSIDES
450PsoriasisOFFSIDES
SIDER
451Pulmonary HypertensionOFFSIDES
452QuadriplegiaOFFSIDES
453Radiation PneumonitisOFFSIDES
454Reaction to azo-dyesCanada Vigilance: 1Canada Vigilance
455Rebound effectOFFSIDES
456Rectal ProlapseOFFSIDES
457Rectal StenosisOFFSIDES
458Residual urineOFFSIDES
459Reticulocyte count increasedOFFSIDES
460Retinal DegenerationSIDER
461Retrosternal painSIDER
462Rheumatoid ArthritisSIDER
463Right upper quadrant painSIDER
464SchizophreniaOFFSIDES
465Sebaceous hyperplasiaOFFSIDES
466Septic ShockOFFSIDES
467Septic embolusOFFSIDES
468ShockSIDER
469Shoulder PainOFFSIDES
470Sigmoidoscopy abnormalOFFSIDES
471Sinus bradycardiaSIDER
472Skin carcinomaSIDER
473Skin hypertrophySIDER
474Skin noduleSIDER
475Speech Disorders19519270CTD
476Spontaneous penile erectionOFFSIDES
477Squamous cell carcinoma of skinOFFSIDES
478Sudden deathSIDER
479Suicide attemptSIDER
480Superficial ThrombophlebitisOFFSIDES
481SweatingSIDER
482SynovitisOFFSIDES
483TensionSIDER
484ThrombophlebitisOFFSIDES
SIDER
485Thyroid atrophyOFFSIDES
486Tongue erythemaCanada Vigilance: 1Canada Vigilance
487Toxic Epidermal NecrolysisSIDER
488TracheobronchitisOFFSIDES
489Ulcerative stomatitisSIDER
490Urinary IncontinenceSIDER
491Urinary tract infectionSIDER
492Urine output increasedSIDER
493Uterine PerforationOFFSIDES
494Vaginal DischargeSIDER
495Vasodilation procedureSIDER
496VasodilationSIDER
497VertigoSIDER
498Weight GainOFFSIDES
499effusionOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.